Mark Jones
8Patents
5h-index
14Co-inventors
60Inventor score
Filing activity: Apr 24, 1989 → Dec 5, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8785626B2 | Benzoxazepin PI3K inhibitor compounds and methods of use | Chemistry; Metallurgy | 54 | Active |
| US8343955B2 | Benzoxazepin PI3K inhibitor compounds and methods of use | Chemistry; Metallurgy | 25 | Active |
| US8242104B2 | Benzoxazepin P13K inhibitor compounds and methods of use | Chemistry; Metallurgy | 21 | Active |
| US8586574B2 | Benzoxazepin PI3K inhibitor compounds and methods of use | Chemistry; Metallurgy | 17 | Active |
| US5002755A | Method of controlling nephrotoxicity of anti-tumor plaintum compounds | Human Necessities | 15 | Expired |
| US9546178B2 | Benzoxazepin PI3K inhibitor compounds and methods of use | Chemistry; Metallurgy | 3 | Active |
| US9670228B2 | Benzoxazepin PI3K inhibitor compounds and methods of use | Chemistry; Metallurgy | 1 | Active |
| US9198918B2 | Benzoxazepin PI3K inhibitor compounds and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.